biora therapeutics
PrivateLast Round
Bankruptcy
Feb 19, 2025
Last Round Size
$46M
Total Funding Raised
$410.5M
Company Overview
Biora Therapeutics (NAS: BIOR) is a biotechnology company focused on developing innovative oral biotherapeutics that enhance therapeutic delivery for gastrointestinal diseases and provide needle-free, oral alternatives for systemic biotherapeutics.
Sector
Biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
biora therapeutics Comps
Related companies by embedding similarity.
biora therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Bankruptcy | Feb 19, 2025 | ||||
| Follow-on Offering | Oct 29, 2024 | ||||
| Debt | Aug 12, 2024 | ||||
| Follow-on Offering | Apr 3, 2024 | ||||
| Follow-on Offering | Aug 19, 2021 | ||||
Private Placement | Jun 10, 2021 |
biora therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about biora therapeutics's valuation, stock price, and market status.
